ARRIVE AI INC (ARAI) Fundamental Analysis & Valuation

NASDAQ:ARAI • US04272H2040

Current stock price

0.95 USD
-0.05 (-4.57%)
At close:
0.9301 USD
-0.02 (-2.09%)
After Hours:

This ARAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ARAI Profitability Analysis

1.1 Basic Checks

  • ARAI had negative earnings in the past year.
  • ARAI had a negative operating cash flow in the past year.
ARAI Yearly Net Income VS EBIT VS OCF VS FCFARAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • With a Return On Assets value of -105.41%, ARAI is not doing good in the industry: 86.96% of the companies in the same industry are doing better.
  • ARAI has a Return On Equity of -217.51%. This is amonst the worse of the industry: ARAI underperforms 82.61% of its industry peers.
Industry RankSector Rank
ROA -105.41%
ROE -217.51%
ROIC N/A
ROA(3y)-578.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARAI Yearly ROA, ROE, ROICARAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 500 -500 1K -1K 1.5K

1.3 Margins

  • ARAI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARAI Yearly Profit, Operating, Gross MarginsARAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

3

2. ARAI Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ARAI remains at a similar level compared to 1 year ago.
  • ARAI has a better debt/assets ratio than last year.
ARAI Yearly Shares OutstandingARAI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M 25M
ARAI Yearly Total Debt VS Total AssetsARAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

  • ARAI has an Altman-Z score of -2.19. This is a bad value and indicates that ARAI is not financially healthy and even has some risk of bankruptcy.
  • ARAI's Altman-Z score of -2.19 is on the low side compared to the rest of the industry. ARAI is outperformed by 73.91% of its industry peers.
  • A Debt/Equity ratio of 0.85 indicates that ARAI is somewhat dependend on debt financing.
  • ARAI's Debt to Equity ratio of 0.85 is on the low side compared to the rest of the industry. ARAI is outperformed by 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z -2.19
ROIC/WACCN/A
WACCN/A
ARAI Yearly LT Debt VS Equity VS FCFARAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 1M -1M 2M -2M

2.3 Liquidity

  • ARAI has a Current Ratio of 1.85. This is a normal value and indicates that ARAI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.85, ARAI is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
  • A Quick Ratio of 1.85 indicates that ARAI should not have too much problems paying its short term obligations.
  • ARAI has a better Quick ratio (1.85) than 69.57% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 1.85
ARAI Yearly Current Assets VS Current LiabilitesARAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

0

3. ARAI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 38.03% over the past year.
EPS 1Y (TTM)38.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ARAI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -49.46% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-188.06%
EPS Next 2Y-86.27%
EPS Next 3Y-49.46%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARAI Yearly Revenue VS EstimatesARAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2025 2026 2027 2M 4M 6M
ARAI Yearly EPS VS EstimatesARAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.1 -0.2 -0.3 -0.4 -0.5

0

4. ARAI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ARAI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ARAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARAI Price Earnings VS Forward Price EarningsARAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARAI Per share dataARAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

  • ARAI's earnings are expected to decrease with -49.46% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-86.27%
EPS Next 3Y-49.46%

0

5. ARAI Dividend Analysis

5.1 Amount

  • No dividends for ARAI!.
Industry RankSector Rank
Dividend Yield 0%

ARAI Fundamentals: All Metrics, Ratios and Statistics

ARRIVE AI INC

NASDAQ:ARAI (3/13/2026, 8:10:06 PM)

After market: 0.9301 -0.02 (-2.09%)

0.95

-0.05 (-4.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)11-14
Earnings (Next)N/A
Inst Owners2.23%
Inst Owner Change1.92%
Ins Owners71.83%
Ins Owner Change0.08%
Market Cap32.50M
Revenue(TTM)98.20K
Net Income(TTM)-10.24M
Analysts82.86
Price Target12.24 (1188.42%)
Short Float %11.42%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 330.95
P/FCF N/A
P/OCF N/A
P/B 6.9
P/tB 7.32
EV/EBITDA N/A
EPS(TTM)-0.33
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0
BVpS0.14
TBVpS0.13
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -105.41%
ROE -217.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-578.42%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 311.19%
Cap/Sales 130.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 1.85
Altman-Z -2.19
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1080.12%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.33%
EPS Next Y-188.06%
EPS Next 2Y-86.27%
EPS Next 3Y-49.46%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-70.1%
EBIT Next 3Y-31.24%
EBIT Next 5YN/A
FCF growth 1Y20.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.73%
OCF growth 3YN/A
OCF growth 5YN/A

ARRIVE AI INC / ARAI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARRIVE AI INC?

ChartMill assigns a fundamental rating of 1 / 10 to ARAI.


Can you provide the valuation status for ARRIVE AI INC?

ChartMill assigns a valuation rating of 0 / 10 to ARRIVE AI INC (ARAI). This can be considered as Overvalued.


How profitable is ARRIVE AI INC (ARAI) stock?

ARRIVE AI INC (ARAI) has a profitability rating of 0 / 10.


What is the financial health of ARRIVE AI INC (ARAI) stock?

The financial health rating of ARRIVE AI INC (ARAI) is 3 / 10.